Hubei Goto Biopharm Group Co., Ltd. (SHE:300966)
29.15
+0.48 (1.67%)
Jul 15, 2026, 3:06 PM CST
53.83% (1Y)
| Market Cap | 3.27B +56.7% |
| Revenue (ttm) | 628.90M +13.6% |
| Net Income | -71.24M |
| EPS | -0.62 |
| Shares Out | 114.21M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.05 (0.16%) |
| Ex-Dividend Date | Jul 16, 2026 |
| Volume | 7,245,153 |
| Open | 28.50 |
| Previous Close | 28.67 |
| Day's Range | 28.17 - 29.70 |
| 52-Week Range | 18.44 - 32.58 |
| Beta | 0.45 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 26, 2026 |